✦ LIBER ✦

Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir

✍ Scribed by Calza, Leonardo; Trapani, Filippo; Salvadori, Caterina; Magistrelli, Eleonora; Manfredi, Roberto; Colangeli, Vincenzo; Di Bari, Maria Assunta; Borderi, Marco; Viale, Pierluigi

Book ID: 121851502
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 106 KB
Volume: 45
Category: Article
ISSN: 0036-5548
DOI: 10.3109/00365548.2012.712213

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Body Composition Changes B

Comparison of Body Composition Changes Between Atazanavir/Ritonavir and Lopinavir/Ritonavir Each in Combination with Tenofovir/Emtricitabine in Antiretroviral-Naïve Patients with HIV-1 Infection

✍ Moyle, Graeme J.; Hardy, Hélène; Farajallah, Awny; DeGrosky, Michelle; McGrath, 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 371 KB

Once-daily atazanavir/ritonavir versus t

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

✍ Jean-Michel Molina; Jaime Andrade-Villanueva; Juan Echevarria; Ploenchan Chetcho 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 246 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of Atazanavir-containing Antiretroviral Regimens, with or without Ritonavir, in Patients who are HIV-positive and Treatment-naïve

✍ Bertz, Richard J.; Persson, Anna; Chung, Ellen; Zhu, Li; Zhang, Jenny; McGrath, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Lipid profiles for nevirapine vs. atazan

Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study)

✍ D Podzamczer; J Andrade-Villanueva; B Clotet; S Taylor; JK Rockstroh; P Reiss; P 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

Randomized comparison of metabolic and r

Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients

✍ SME Vrouenraets; FWNM Wit; E Fernandez Garcia; GJ Moyle; AG Jackson; C Allavena; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

Long-term (96-week) follow-up of antiret

Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial

✍ J Ghosn; P Flandre; I Cohen-Codar; P-M Girard; M-L Chaix; F Raffi; P Dellamonica 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB